MAM
TMDX icon

Morse Asset Management’s Transmedics TMDX Stock Holding History

Morse Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-812
Closed -$80.7K – 448
2026
Q1 		$80.7K Buy
812
+126
+18% +$16.4K 0.02% 198
2025
Q4 		$83.5K Buy
+686
New +$86.1K 0.02% 186
2025
Q1 		– Sell
-50
Closed -$3.12K – 379
2024
Q4 		$3.12K Sell
50
-5,191
-99% -$483K ﹤0.01% 286
2024
Q3 		$823K Buy
+5,241
New +$808K 0.18% 102

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Morse Asset Management's TMDX Position: Q2 2026 in Review

Morse Asset Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 812 shares — an estimated $80.7K sold.

Morse Asset Management first reported a position in TMDX in Q3 2024 and held it in 4 quarters. The position peaked at $823K in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Morse Asset Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Morse Asset Management sold 812 Transmedics shares in Q2 2026, an estimated $80.7K.
  • Morse Asset Management first reported a position in Transmedics in Q3 2024 and held it in 4 quarters.
  • Morse Asset Management's Transmedics position peaked at $823K in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.